Bluebird 'Potentially The Walter White Of CAR T Therapy,' Says BTIG
December 01, 2016 at 14:16 PM EST
After market close on Wednesday, bluebird bio Inc (NASDAQ: BLUE) released early data on the relapsed/refractory multiple myeloma study. ...